Luke Schmerold

What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy

Eric Roeland, Kathryn J. Ruddy, Thomas W. LeBlanc et al. · Journal of the National Comprehensive Cancer Network · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +13

Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin

Rudolph M. Navari, Kathryn J. Ruddy, Thomas W. LeBlanc et al. · The Oncologist · 2020 · 22 citations · Full text

Medicine, Oncology, Pharmacology +16

Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey

Mark Peyrot, Magaly Perez‐Nieves, Jasmina Ivanova et al. · Current Medical Research and Opinion · 2017 · 21 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey

Magaly Perez‐Nieves, Jasmina Ivanova, Irene Hadjiyianni et al. · Current Medical Research and Opinion · 2017 · 16 citations · Full text

Medicine, Endocrinology, Internal Medicine +14

Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles

Rudolph M. Navari, G. Binder, Alex Molassiotis et al. · The Oncologist · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +12